Patents Represented by Attorney, Agent or Law Firm Kirk Baumeister
  • Smooth muscle cell-derived migration factor
    Patent number: 5916758
    Abstract: Isolated nucleic acid encoding human smooth muscle cell-derived migration factor, protein obtainable from the nucleic acid, recombinant host cells transformed with the nucleic acid and use of the protein and nucleic acid sequence are disclosed.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: June 29, 1999
    Inventors: Mark Robert Hurle, Peter Colon McDonnell, Dean Edward McNulty, Craig Alan Rosen, Ivo Rogulia Siemens, Peter Ronald Young, Tian-Li Yue
  • Growth factor receptor-binding insulin receptor
    Patent number: 5840536
    Abstract: Isolated nucleic acid encoding a growth factor receptor binding protein-insulin receptor isoform, protein obtainable from the nucleic acid, recombinant host cells transformed with the nucleic acid and use of the protein and nucleic acid sequence are disclosed.
    Type: Grant
    Filed: July 9, 1997
    Date of Patent: November 24, 1998
    Inventors: Damien J. Dunnington, James D. Frantz, Steven E. Shoelson
  • Protein
    Patent number: 5798106
    Abstract: This invention relates to a novel protein capable of inducing an immune response protective against human malarial infection caused by Plasmodium falciparum, and to the cloning and expression of a gene encoding the said protein. The invention further relates to novel vaccines comprising the said protein and to their use in the vaccination of humans at risk from malaria.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: August 25, 1998
    Assignee: University of Nijmegan
    Inventors: Johannes Gerardus Ghislain Schoenmakers, Rudolph Nicholaas Hendrik Konings, Inge Irma Maria Dominique Moelans
  • DNA encoding a plasmodium 16kD protein
    Patent number: 5798105
    Abstract: A DNA encoding a 16 kD protein capable of inducing an immune response protective against human malarial infection caused by Plasmodium falciparum, and to the cloning and expression of a gene encoding the said protein. The invention further relates to novel vaccines comprising the said protein and to their use in the vaccination of humans at risk from malaria.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: August 25, 1998
    Assignee: University of Nijmegan
    Inventors: Johannes Geradus Ghislain Schoenmakers, Rudolph Nicolaas Hendrik Konings, Inge Irma Maria Dominique Moelans
  • NERF genes
    Patent number: 5721113
    Abstract: Isolated nucleic acids encoding human lymphoid-specific transcription factors NERF-1 and NERF-2, proteins obtainable from the nucleic acids, recombinant host cells transformed with the nucleic acids and use of the proteins and nucleic acid sequences are dislcosed.
    Type: Grant
    Filed: January 3, 1995
    Date of Patent: February 24, 1998
    Assignee: Human Genome Sciences, Inc.
    Inventors: Towia Aron Libermann, Joerg Peter Oettgen, Charles A. Kunsch
  • Method for screening compositions
    Patent number: 5681708
    Abstract: A method for identifying new classes of chemical entities which dissociate specific protein-protein complexes. Antibodies are employed to specifically quantitate target protein-protein complexes.
    Type: Grant
    Filed: October 12, 1994
    Date of Patent: October 28, 1997
    Assignee: SmithKline Beecham Corporation
    Inventor: Shouki Kassis
  • Method for analyzing partial gene sequences
    Patent number: 5618672
    Abstract: An computer-based iterative method for analyzing partial gene sequences. Putative gene assemblies are built from partial gene sequences by the method. A series of pre-processing steps prior to assembly allows efficient and accurate assembly of large amounts of partial gene sequences.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: April 8, 1997
    Assignee: SmithKline Beecham Corporation
    Inventors: Robert K. Stodola, Frank L. Tobin, Arthur L. Williams, Jr.